GelStat makes plans to turn around business and drive sales
GelStat Corporation chief executive officer Gerald Kieft on Tuesday outlined the company’s turnaround plans in an open letter to shareholders.
“While we have encountered a number of challenges expected with any turnaround situation, we are pleased to report the core fundamentals are sound and we are more excited than ever about the company’s prospects,” he wrote.
To date, the company has re-established distribution and product availability through Drugstore.com and Amazon.com and performed a physical inventory audit Sept. 13, tablulating 942,120 boxes of GelStat Migraine four count and GelStat Migraine eight count collectively. Kieft estimated the potential revenue from the sale of this inventory would fall between $3.2 million and $10 million depending on the sales channel.
Moving forward, GelStat plans to drive direct-to-consumer sales through cost per acquisition Internet campaigns, infomercials, television, radio and print advertising and to reseed its products through wholesalers and other distribution channels into retail.
Walgreens gives customers direction on cough-cold OTC dosing for children
DEERFIELD, Ill. Walgreens has said that it will advise its customers on the proper, safe use of over-the-counter cough and cold remedies by adding in-store signage to shelves and making its pharmacists available for consultations.
After the announcement from the CHPA Tuesday that cough-cold remedies should not be administered to children under age 4, many cough-cold remedy makers are revising their product labels to reflect the new dosing recommendations before the upcoming cold season. Walgreens has made a commitment to make sure the most current labeled cough and cold remedies will be available during the label-upgrading swap, and newly labeled products will be on shelves as soon as they are available.
The FDA has issued a statement that parents should take precautions when administering cough-cold medicines to children, including, checking active ingredients on the Drug Facts product labeling, avoiding given children two products with the same active ingredients at the same time, following directions, using the appropriate measuring instruments, selecting cough-cold medicines with child-proof caps, recognizing that cough-old remedies do not shorten the length of illness but only treat symptoms, not using cough-cold products for sedation and calling a doctor or pharmacist if any adverse reactions occur after administering.
Metabolife releases diet aid to help keep the weight off
NEW YORK Metabolife last week launched part two of a two-stage weight loss program called Break Through, a dietary supplement designed to help people who’ve lost the weight keep it lost.
“Eons before we had artificial shelter and heating and cooling environments, our bodies were built to survive a naturally harsh environment and scarcity of food due to seasonal changes and nomadic moves from one place to another,” stated Greg Grochoski, Metabolife chief science officer. “Even today, an initial weight loss signals the body to go into a conservation mode as it biologically expects winter or a move to a scarce food area. We are built to conserve fat to protect the internal organs until spring arrives or the situation changes. This ‘rebound’ is therefore a natural reaction, but a problem in today’s world, when we lose weight for different reasons. We found that we can keep thermogenesis (an aspect of metabolism) at a higher, stabilized and healthy rate for a full eight weeks which can help the body continue to slough off excess fat.”
“In our clinical trials at the University of Copenhagen, we started with a group of 80 obese individuals who lost a significant amount of weight on a hypocaloric diet,” a doctor who led the study, Soren Toubro, said. “The effect of adding our compound was a sustained increase in thermogenesis for eight weeks combined with an improved reduction in fat mass. The results of the double blind study are exciting because we were able to maintain the metabolic increase from week one to week eight.”
Break Through conains a patent-pending combination of key nutrients such as green tea, caffeine, cayenne and the amino acid L-Tyrosine, the company reported. Suggested retail price is $29.99.